The role of the tumor suppressor RUNX3 in giant cell tumor of the bone

International Journal of Oncology

Volumn 40, Issue 3, 2012, Pages 673-678

  Han, Ya Xin ^a   Liang, De Yong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Giant cell tumor of bone; Methylation; RUNX3

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR RUNX3;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE SEQUENCE; GIANT CELL TUMOR; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BONE NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DISEASE PROGRESSION; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GIANT CELL TUMOR OF BONE; HUMANS; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TRANSFECTION;

EID: 84863402259     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1249     Document Type: Article

References (33)

1. Mendenhall WM, Zlotecki RA, Scarborough MT, et al: Giant cell tumor of bone. Am J Clin Oncol 29: 96-99, 2006. (Pubitemid 44356723)
2. Parkin DM: Global cancer statistics in the year. Lancet Oncol 2: 533-543, 2000.
3. Lee CH, Espinosa I, Jensen KC, et al: Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone. Mod Pathol 21: 531-539, 2008. (Pubitemid 351589649)
4. Khalil ESA, Younis A, Aziz SA, et al: Surgical management for giant cell tumor of bones. J Egypt Natl Canc Inst 16: 145-152, 2004.
5. Turcotte RE: Giant cell tumor of bone. Orthop Clin North Am 35: 35-51, 2006.
6. Ogawa E, Maruyama M, Kagoshima H, et al: PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci USA 90: 6859-6863, 1993. (Pubitemid 23207313)
7. Lund AH and van Lohuizen M: RUNX: a trilogy of cancer genes. Cancer Cell 1: 213-215, 2002. (Pubitemid 41039143)
8. Otto F, Kanegane H, Mundlos S, et al: Mutations in the RUNX2 gene in patients with cleidocranial dysplasia. Hum Mutat 19: 209-216, 2002. (Pubitemid 34195181)
9. Blyth K, Cameron ER, Neil JC, et al: The RUNX genes: gain or loss of function in cancer. Nat Rev Cancer 5: 376-387, 2005. (Pubitemid 40637829)
10. Kohu K, Sato T, Ohno S, et al: Overexpression of the Runx3 trans- cription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage. J Immunol 174: 2627-2636, 2005. (Pubitemid 40279676)
11. Xiao WH and Liu WW: Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World J Gastroenterol 10: 376-380, 2004.
12. Li QL, Ito K, Sakakura C, et al: Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109: 113-124, 2002. (Pubitemid 34327521)
13. Kang GH, Lee S, Lee HJ, et al: Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. J Pathol 202: 233-240, 2004. (Pubitemid 38208661)
14. Lee CW, Ito K and Ito Y: Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer. Cancer Res 70: 4243-4252, 2010.
15. Lau QC, Raja E, Salto-Tellez M, et al: RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res 66: 6512-6520, 2006. (Pubitemid 44085605)
16. Kim WJ, Kim EJ, Jeong P, et al: RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res 65: 9347-9354, 2005. (Pubitemid 41508002)
17. Tsunematsu T, Kudo Y, Iizuka S, et al: RUNX3 has an oncogenic role in head and neck cancer. PLoS One 4: e5892, 2009.
18. Ghert M, Simunovic N, Cowan RW, et al: Properties of the stromal cell in giant cell tumor of bone. Clin Orthop Relat Res 459: 8-13, 2007. (Pubitemid 46878187)
19. Mak IW, Turcotte RE, Popovic S, et al: AP-1 as a regulator of MMP-13 in the stromal cell of giant cell tumor of bone. Biochem Res Int 2011: 164197, 2011.
20. Mak IW, Cowan RW, Popovic S, et al: Upregulation of MMP-13 via Runx2 in the stromal cell of giant cell tumor of bone. Bone 45: 377-386, 2009.
21. Campanacci M, Baldini N, Boriani S, et al: Giant-cell tumor of bone. J Bone Joint Surg Am 69: 106-114, 1987. (Pubitemid 17030377)
22. Kim TY, Lee HJ, Hwang KS, et al: Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest 84: 479-484, 2004. (Pubitemid 41656475)
23. Schulmann K, Sterian A, Berki A, et al: Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's associated neoplastic progression and predicts progression risk. Oncogene 24: 4138-4148, 2005. (Pubitemid 40897058)
24. Subramaniam MM, Chan JY, Soong R, et al: RUNX3 inactivation in colorectal polyps arising through different pathways of colonic carcinogenesis. Am J Gastroenterol 104: 426-436, 2009.
25. Licchesi JD, Westra WH, Hooker CM, et al: Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung. Carcinogenesis 29: 895-904, 2008. (Pubitemid 351982232)
26. Merlo A, Herman JG, Mao L, et al: 5-CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1: 686-692, 1995.
27. Zochbauer-Muller S, Fong KM, et al: Aberrant promoter methy- lation of multiple genes in non-small cell lung cancers. Cancer Res 61: 249-255, 2001. (Pubitemid 32095725)
28. Yanagawa N, Tamura G, Oizumi H, et al: Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci 94: 589-592, 2003. (Pubitemid 36975012)
29. WAF1/Cip1 expression in cooperation with transforming growth factor β-activated SMAD. Mol Cell Biol 25: 8097-8107, 2005.
30. Lee CW, Chuang LS, Kimura S, et al: RUNX3 functions as an oncogene in ovarian cancer. Gynecol Oncol 122: 410-417, 2011.
31. Yamamura Y, Lee WL, Inoue K, et al: RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells. J Biol Chem 281: 5267-5276, 2006. (Pubitemid 43847791)
32. Yano T, Ito K, Fukamachi H, et al: The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis. Mol Cell Biol 26: 4474-4488, 2006. (Pubitemid 43877568)
33. Inoue KI and Ito Y: Neuroblastoma cell proliferation is sensitive to changes in levels of RUNX1 and RUNX3 protein. Gene 28: 1379-1384, 2009.